Literature DB >> 8233030

Postnatal ontogeny of the rat brain neurotensin receptor mRNA.

E Hermans1, A P Jeanjean, P M Laduron, J N Octave, J M Maloteaux.   

Abstract

Total RNA was purified from rat forebrain at different postnatal ages and analyzed by Northern blot using a specific neurotensin receptor RNA probe. The rat neurotensin receptor mRNA was present in high amount during the first 10 days of life. Thereafter, it rapidly decreased and was undetected after 20 days. [3H]neurotensin binding experiments performed on the same tissues indicated that the total amount of neurotensin receptors increased during the first week and was maximal between day 7 and day 10. This plateau was followed by an important loss (70%) of neurotensin receptors. These results indicate that an important reduction in the genetic expression of the neurotensin receptor after day 10 may probably account for the [3H]neurotensin binding profile observed in rat forebrain during the postnatal ontogeny.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233030     DOI: 10.1016/0304-3940(93)90639-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.

Authors:  Shinnyi Chou; Collin Davis; Sean Jones; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2014-11-26       Impact factor: 3.533

2.  High-affinity neurotensin receptor is involved in phosphoinositide turnover increase by inhibition of sodium pump in neonatal rat brain.

Authors:  Susana Pereyra-Alfonso; María Del Valle Armanino; Carolina Vázquez; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2008-08-29       Impact factor: 3.996

Review 3.  The Role of Central Neurotensin in Regulating Feeding and Body Weight.

Authors:  Jariel Ramirez-Virella; Gina M Leinninger
Journal:  Endocrinology       Date:  2021-05-01       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.